154 related articles for article (PubMed ID: 8797463)
1. Complications of intravenous immune globulin treatment in neurologic disease.
Brannagan TH; Nagle KJ; Lange DJ; Rowland LP
Neurology; 1996 Sep; 47(3):674-7. PubMed ID: 8797463
[TBL] [Abstract][Full Text] [Related]
2. Adverse effects of treatment with intravenous immunoglobulins for neurological diseases.
Wittstock M; Zettl UK
J Neurol; 2006 Sep; 253 Suppl 5():V75-9. PubMed ID: 16998759
[TBL] [Abstract][Full Text] [Related]
3. Therapy with intravenous immunoglobulins: complications and side-effects.
Wittstock M; Benecke R; Zettl UK
Eur Neurol; 2003; 50(3):172-5. PubMed ID: 14530624
[TBL] [Abstract][Full Text] [Related]
4. Smallpox vaccination and adverse reactions. Guidance for clinicians.
Cono J; Casey CG; Bell DM;
MMWR Recomm Rep; 2003 Feb; 52(RR-4):1-28. PubMed ID: 12617510
[TBL] [Abstract][Full Text] [Related]
5. Safety of intravenous immunoglobulin in the elderly treated for a dysimmune neuromuscular disease.
Lozeron P; Not A; Theaudin M; Denier C; Masnou P; Sarov M; Adam C; Cauquil C; Adams D
Muscle Nerve; 2016 May; 53(5):683-9. PubMed ID: 26467654
[TBL] [Abstract][Full Text] [Related]
6. Corticosteroid prophylaxis for neurologic complications of intravenous immunoglobulin G therapy in childhood immune thrombocytopenic purpura.
Jayabose S; Mahmoud M; Levendoglu-Tugal O; Sandoval C; Ozkaynak F; Giamelli J; Visintainer P
J Pediatr Hematol Oncol; 1999; 21(6):514-7. PubMed ID: 10598663
[TBL] [Abstract][Full Text] [Related]
7. Intravenous gammaglobulin (IVIg) for treatment of CIDP and related immune-mediated neuropathies.
Brannagan TH
Neurology; 2002 Dec; 59(12 Suppl 6):S33-40. PubMed ID: 12499469
[TBL] [Abstract][Full Text] [Related]
8. Acute renal failure and intravenous immune globulin: sucrose nephropathy in disguise?
Perazella MA; Cayco AV
Am J Ther; 1998 Nov; 5(6):399-403. PubMed ID: 10099084
[TBL] [Abstract][Full Text] [Related]
9. Frequency of adverse events associated with intravenous immunoglobulin therapy in patients with pemphigus or pemphigoid.
Gürcan HM; Ahmed AR
Ann Pharmacother; 2007 Oct; 41(10):1604-10. PubMed ID: 17785614
[TBL] [Abstract][Full Text] [Related]
10. Acute renal failure after large doses of intravenous immune globulin.
Haskin JA; Warner DJ; Blank DU
Ann Pharmacother; 1999; 33(7-8):800-3. PubMed ID: 10466908
[TBL] [Abstract][Full Text] [Related]
11. Intravenous immunoglobulin: adverse effects and safe administration.
Orbach H; Katz U; Sherer Y; Shoenfeld Y
Clin Rev Allergy Immunol; 2005 Dec; 29(3):173-84. PubMed ID: 16391392
[TBL] [Abstract][Full Text] [Related]
12. Intravenous immunoglobulin induced-nephropathy: a complication of IVIG therapy.
Ahsan N
J Nephrol; 1998; 11(3):157-61. PubMed ID: 9650125
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature.
Marie I; Maurey G; Hervé F; Hellot MF; Levesque H
Br J Dermatol; 2006 Oct; 155(4):714-21. PubMed ID: 16965420
[TBL] [Abstract][Full Text] [Related]
14. Myocardial infarction associated with intravenous immune globulin.
Stenton SB; Dalen D; Wilbur K
Ann Pharmacother; 2005 Dec; 39(12):2114-8. PubMed ID: 16288078
[TBL] [Abstract][Full Text] [Related]
15. Safety of intravenous immunoglobulin (IVIG) therapy.
Katz U; Achiron A; Sherer Y; Shoenfeld Y
Autoimmun Rev; 2007 Mar; 6(4):257-9. PubMed ID: 17317619
[TBL] [Abstract][Full Text] [Related]
16. Acute ST elevation myocardial infarction during intravenous immunoglobulin infusion.
Barsheshet A; Marai I; Appel S; Zimlichman E
Ann N Y Acad Sci; 2007 Sep; 1110():315-8. PubMed ID: 17911446
[TBL] [Abstract][Full Text] [Related]
17. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
Ririe MR; Blaylock RC; Morris SE; Jung JY
J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulins in neurological disorders: safety issues.
Eibl MM
Neurol Sci; 2003 Oct; 24 Suppl 4():S222-6. PubMed ID: 14598047
[TBL] [Abstract][Full Text] [Related]
19. Thromboembolic complications of intravenous immunoglobulin treatment.
Vucic S; Chong PS; Dawson KT; Cudkowicz M; Cros D
Eur Neurol; 2004; 52(3):141-4. PubMed ID: 15479982
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases.
Dalakas MC
Neurology; 1998 Dec; 51(6 Suppl 5):S2-8. PubMed ID: 9851723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
